During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no ...

Because cisplatin and carboplatin were prioritized for patients with curable cancers during the shortage, the researchers ...

An analysis of national data found that short-term mortality was not impacted for patients with advanced cancers during the shortage of the generic platinum chemotherapy drugs cisplatin and ...

During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no difference in mortality rates among patients with advanced cancer compared ...

Study demonstrates how metabolic imaging differentiates high and low oxidative phosphorylation (OXPHOS) subtypes of ...

Patients with HER2 gene amplification, normal left ventricular ejection fraction (LVEF), and resistant relapse after first- or second-line paclitaxel/carboplatin chemotherapy received paclitaxel ...

Teos' Phase II trial for inupadenant met its primary and secondary endpoints but offered little more than existing treatments ...

On rare occasions you might have it over 24 hours, when you would stay in hospital overnight. If you have epithelial ovarian cancer, you usually have the chemotherapy drug carboplatin. You might have ...

Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of ...